677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke

Journal of the Neurological Sciences

Volumn 155, Issue 2, 1998, Pages 156-162

  Lalouschek, Wolfgang ^a   Aull, Susanne ^a   Korninger, Lisa ^a   Mannhalter, Christine ^a   Pabinger Fasching, Ingrid ^a   Schmid, Rainer W ^a   Peter Schnider, ^a   Zeiler, Karl ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cerebrovascular diseases; Creatinine; Folate; Genetic disorders; Homocyst(e)ine; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CREATININE; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; DATA ANALYSIS; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CEREBROVASCULAR DISORDERS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES; RISK FACTORS; VITAMIN B 12;

EID: 0032485522     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00311-0     Document Type: Article

References (28)

1. Adams M., Smith P.D., Martin D., Thompson J.R., Lodwick D., Samani N.J. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q. J. Med. 89:1996;437-444.
2. Alfthan G., Pekkanen J., Jauhiainen M.et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 106:1994;9-19.
3. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422:1987;43-52.
4. Araki A., Sako Y., Fukushima Y., Matsumoto M., Asada T., Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 79:1989;139-146.
5. Boers G.H.J., Smals A.G.H., Trijbels F.J.M.et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med. 313:1985;709-715.
6. öm et al., 1984.
7. Brattström L.E., Hardebo J.E., Hultberg B.L. Moderate homocysteinemia-A possible risk factor for arteriosclerotic cerebrovascular disease. Stroke. 15:1984;1012-1016.
8. öm et al., 1990.
9. Brattström L., Israelsson B., Norrving B.et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis. 81:1990;51-60.
10. öm et al., 1992.
11. Brattström L., Lindgren A., Israelsson B.et al. Hyperhomocysteinaemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur. J. Clin. Invest. 22:1992;214-221.
12. Clarke R., Daly L., Robinson K.et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N. Engl. J. Med. 324:1991;1149-1155.
13. Coull B.M., Malinow M.R., Beamer N., Sexton G., Nordt F., de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke. 21:1990;572-576.
14. Frosst P., Blom H.J., Milos R.et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113.
15. Glueck C.J., Shaw P., Lang J.E., Tracy T., Sieve-Smith L., Wang Y. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am. J. Cardiol. 75:1995;132-136.
16. Guttormsen A.B., Svarstad E., Ueland P.M., Refsum H. Elimination of homocysteine from plasma in subjects with endstage renal failure. Ir. J. Med. Sci. 164:1995;8.
17. Jacques P.F., Bostom A.G., Williams R.R.et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:1996;7-9.
18. Kang S.-S., Wong P.W.K. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis. 119:1996;135-138.
19. Kluijtmans L.A.J., van den Heuvel L.P.W., Boers G.H.J.et al. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet. 58:1996;35-41.
20. Lindgren A., Brattström L., Norrving B., Hultberg B., Andersson A., Johansson B.B. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke. 26:1995;795-800.
21. Markus H., Ali N., Swaminathan R., Powell J. MTHFR C677T polymorphism, homocysteine and cerebrovascular disease (abstract). Cerebrovasc. Dis. 6:1996;19.
22. Perry I.J., Refsum H., Morris R.W., Ebrahim S.B., Ueland P.M., Shaper A.G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1995;1395-1398.
23. Stabler S.P., Marcell P.D., Podell E.R., Allen R.H. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal. Biochem. 162:1987;185-196.
24. Taylor L.M. Jr., de Frang R.D., Harris E.J. Jr., Porter J.M. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J. Vasc. Surg. 13:1991;128-136.
25. Ueland P.M., Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J. Lab. Clin. Med. 114:1989;473-501.
26. Verhoef P., Hennekens C.H., Malinow M.R., Kok F.J., Willett W.C., Stampfer M.J. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 25:1994;1924-1930.
27. Whisnant J.P., Basford J.R., Bernstein E.F.et al. Classification of cerebrovascular diseases III. Stroke. 21:1990;637-676.
28. 677T mutation. Arterioscler. Thromb. Vasc. Biol. 16:1996;878-882.